Not all insulin pumps are created equal

 

See how the MiniMedTM 780G system compares.

Spinning MiniMed 780G pump

Compare latest insulin pump systems

Omnipod® 5 with Dexcom G7®

Tandem Control IQ with Dexcom G7®

Beta Bionics® iLet with Dexcom G7®

Meal DetectionTM technology
notices rapid rise of sugar levels

Yes
No
No
No

Auto correction bolus

Every 5 mins
 Up to 8% of the TDD§

Every 5 mins

Every 60 mins
Limited to 6 units

Every 5 mins
Limited to 3 units

Automated basal delivery
every 5 minutes

Yes
Yes
Yes
Yes

Compatible infusion set for up to 7-day wear

Yes
No
No
No

Flexible glucose target
as low as 100 mg/dL

Yes
No
No
No

Max insulin capacity

300 units

200 units

200 units (Mobi)
300 units (Tslim)

180 units

Available in multiple languages 
English, Spanish, simplified Chinese

Yes
No
No
No

Personalized insights program based on sensor data

Yes
No
No
No

Replace your infusion set less often

Only the MiniMedTM 780G system with the ExtendedTM infusion set can be worn for up 7 days — that’s twice as long as any other infusion set on the market.

You deserve life with fewer interruptions — make the switch!

Don’t let your current diabetes technology hold you back!

If you currently use an in-warranty insulin pump from another manufacturer, you may be eligible for our Switch2System program when you trade in your current device.

Simply trade in your existing pump and pay an upgrade fee of just $499 to switch to the MiniMedTM 780G system. If it doesn’t work out, no problem! Just return it within 90 days.A

 

Customer reviews

Real feedback from people taking control of their diabetes management.

Footnotes

† Compared to 3-day infusion sets.
‡ Refers to SmartGuard™ feature. Individual results may vary.
◊ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.

References

  1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
  2. Individual results may vary.
  3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).

 

A. Switch2System terms and conditions

  • Customers with more than six months remaining on their competitive pump warranty (or 5-year Medicare guideline) are eligible for the Switch2System Program.
  • A $499 payment will be required to use this program. This price includes one (1) insulin pump, one (1) compatible transmitter, one (1) month of consumables and one (1) month of sensors.
  • Customers enrolled in federal, state, or government-funded healthcare plans are excluded from receiving a transmitter and sensors from this program and cannot participate in a payment plan.
  • An ABN will be required to utilize this program for all Medicare customers.
  • Customers may return product that has been shipped as part of this program up to 90 days from the date of shipment.
  • Customers must return their competitor pump or receiver within 90 days. Customers who do not return their pump will be charged $4,500.
  • This program does not extend the warranty period of the replaced pump. The customer’s current pump warranty timeline will not change by purchasing a pump through this program.
  • Customers should verify that their insurance provider will support transitioning to the new pump, as it could affect ongoing coverage of their future pump supplies.
  • Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by MiniMed and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available information any information that MiniMed may provide concerning the discount.
  • MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to purchase a pump, CGM and supplies. Other restrictions may apply.
  • Medicare customers within a 13-month rental period cannot participate in this program.
  • Customers using Kaiser health plans are excluded from this program.
  • Pricing, terms, and conditions are subject to change at any time and without notice.

B. Flex payment plan terms and conditions

  • $49/month estimate is calculated based on average out-of-pocket cost paid over 48 months.
  • Monthly payments include a $6/month service fee.
  • Final cost may be higher or lower than $49/month depending on individual insurance.
  • Patient may elect to pay a portion or all of the upfront cost at any time, without penalty.
  • Starter kit includes one (1) transmitter and a 90-day supply of sensors, infusion sets, and reservoirs associated with your insulin pump.
  • Monthly payments for Flex do not include ongoing supplies except for the first 90 days. To continue using pump therapy, patients must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
  • No upfront payment is required and first month payment will begin 30-60 days after pump shipment. Individual payment timelines may vary.
  • MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
  • A valid prescription will be required to purchase. Other restrictions may apply.
  • Program terms are subject to change at any time and without notice.

Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor

The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.

WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.

©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.